Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -159,307 | -42,220 | -17,622 | -166,014 | -110,936 |
| Depreciation Amortization | 1,005 | 674 | 331 | 1,172 | 810 |
| Accounts payable and accrued liabilities | -1,065 | 2,123 | 359 | -7,804 | -3,217 |
| Other Working Capital | -13,164 | -5,793 | -4,997 | 18,518 | -9,813 |
| Other Operating Activity | 115,630 | 6,264 | 1,744 | 65,738 | 20,054 |
| Operating Cash Flow | $-56,901 | $-38,952 | $-20,185 | $-88,390 | $-103,102 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,852 | -3,852 | -3,900 | -20,619 | -18,310 |
| Purchase Sale Intangibles | -3,500 | N/A | N/A | -4,250 | -4,250 |
| Other Investing Activity | -3,490 | 0 | 0 | -4,311 | -4,250 |
| Investing Cash Flow | $-7,342 | $-3,852 | $-3,900 | $-24,930 | $-22,560 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 141,281 | 550 | 50 | 41,857 | 11,893 |
| Other Financing Activity | -640 | -543 | -420 | 10,240 | -1,028 |
| Financing Cash Flow | $140,641 | $7 | $-370 | $52,097 | $10,865 |
| Beginning Cash Position | 90,517 | 90,517 | 90,517 | 151,740 | 151,740 |
| End Cash Position | 166,915 | 47,720 | 66,062 | 90,517 | 36,943 |
| Net Cash Flow | $76,398 | $-42,797 | $-24,455 | $-61,223 | $-114,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,901 | -38,952 | -20,185 | -88,390 | -103,102 |
| Capital Expenditure | -3,852 | -3,852 | -3,900 | -20,619 | -18,310 |
| Free Cash Flow | -60,753 | -42,804 | -24,085 | -109,009 | -121,412 |